Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma

BACKGROUND: There is no effective systemic therapy for metastatic adrenal cortical carcinoma (ACC) after failure of platinum-based chemotherapy. The efficacies of single-agent oral multikinase inhibitors (MKIs) or salvage immune checkpoint inhibitors (CPIs) have been very limited. It is unknown whet...

Descripción completa

Detalles Bibliográficos
Autores principales: Bedrose, Sara, Miller, Kevin Charles, Altameemi, Lina, Ali, Mohamed S, Nassar, Sameh, Garg, Naveen, Daher, Marilyne, Eaton, Keith D, Yorio, Jeffrey Thomas, Daniel, Davey B, Campbell, Matthew, Bible, Keith C, Ryder, Mabel, Chintakuntlawar, Ashish V, Habra, Mouhammed Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394183/
https://www.ncbi.nlm.nih.gov/pubmed/32737143
http://dx.doi.org/10.1136/jitc-2020-001009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394183/
https://www.ncbi.nlm.nih.gov/pubmed/32737143
http://dx.doi.org/10.1136/jitc-2020-001009

Ejemplares similares